Vasily Vasko

4.2k total citations
21 papers, 2.4k citations indexed

About

Vasily Vasko is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Vasily Vasko has authored 21 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Vasily Vasko's work include Thyroid Cancer Diagnosis and Treatment (17 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer-related Molecular Pathways (7 papers). Vasily Vasko is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (17 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Cancer-related Molecular Pathways (7 papers). Vasily Vasko collaborates with scholars based in United States, France and Italy. Vasily Vasko's co-authors include Mingzhao Xing, Matthew D. Ringel, Motoyasu Saji, Adel K. El‐Naggar, Peng Hou, Julie Di Cristofaro, О. С. Ларін, Shuiying Hu, Giovanni Tallini and Dingxie Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Vasily Vasko

21 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vasily Vasko United States	18	1.4k	1.2k	954	389	375	21	2.4k
Piera Mondellini Italy	25	1.2k 0.9×	1.3k 1.1×	1.0k 1.1×	479 1.2×	397 1.1×	37	2.6k
Ginesa García‐Rostán Spain	20	1.2k 0.8×	765 0.6×	636 0.7×	366 0.9×	328 0.9×	27	1.9k
Minjing Zou Saudi Arabia	30	1.0k 0.7×	1.1k 0.9×	638 0.7×	389 1.0×	420 1.1×	71	2.1k
Todd G. Kroll United States	19	1.3k 0.9×	1.5k 1.2×	715 0.7×	499 1.3×	275 0.7×	23	2.8k
Iñigo Landa United States	24	1.9k 1.3×	1.0k 0.9×	983 1.0×	602 1.5×	363 1.0×	46	3.0k
Donata Vitagliano Italy	19	587 0.4×	920 0.8×	1.0k 1.1×	163 0.4×	235 0.6×	29	1.9k
Vasyl Vasko United States	21	882 0.6×	659 0.5×	602 0.6×	200 0.5×	104 0.3×	38	1.7k
Carmelo Nucera United States	21	839 0.6×	775 0.6×	491 0.5×	122 0.3×	198 0.5×	38	1.4k
Fatima Rangwala United States	14	421 0.3×	618 0.5×	557 0.6×	177 0.5×	260 0.7×	34	1.6k
Anna L. Stratford Canada	24	503 0.4×	1.2k 1.0×	567 0.6×	122 0.3×	129 0.3×	27	1.9k

Countries citing papers authored by Vasily Vasko

Since Specialization

Citations

This map shows the geographic impact of Vasily Vasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasily Vasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasily Vasko more than expected).

Fields of papers citing papers by Vasily Vasko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasily Vasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasily Vasko. The network helps show where Vasily Vasko may publish in the future.

Co-authorship network of co-authors of Vasily Vasko

This figure shows the co-authorship network connecting the top 25 collaborators of Vasily Vasko. A scholar is included among the top collaborators of Vasily Vasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasily Vasko. Vasily Vasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gomes-Lima, Cristiane, Leila Shobab, Di Wu, et al.. (2021). Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?. Frontiers in Endocrinology. 12. 623182–623182. 13 indexed citations

2.

Vasko, Vasily, Lianbo Yu, Parmeet K. Manchanda, et al.. (2014). Follicular Thyroid Cancers Demonstrate Dual Activation of PKA and mTOR as Modeled by Thyroid-Specific Deletion of Prkar1a and Pten in Mice. The Journal of Clinical Endocrinology & Metabolism. 99(5). E804–E812. 27 indexed citations

3.

Saji, Motoyasu, Vasily Vasko, Krista M. D. La Perle, et al.. (2011). Akt1 deficiency delays tumor progression, vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene. 30(42). 4307–4315. 41 indexed citations

4.

Bekaii‐Saab, Tanios, Mitch A. Phelps, Xiaobai Li, et al.. (2011). Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers. Journal of Clinical Oncology. 29(17). 2357–2363. 232 indexed citations

5.

Liu, Zhi, Dingxie Liu, Ermal Bojdani, et al.. (2010). IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer. Clinical Cancer Research. 16(24). 6009–6018. 55 indexed citations

6.

Ларін, О. С., et al.. (2010). Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies. International Journal of Pediatric Endocrinology. 2010. 1–5. 11 indexed citations

7.

Ларін, О. С., et al.. (2010). Thyroid Fine Needle Aspiration Biopsies in Children: Study of Cytological-Histological Correlation and Immunostaining with Thyroid Peroxidase Monoclonal Antibodies. International Journal of Pediatric Endocrinology. 2010(1). 690108–690108. 4 indexed citations

8.

Liu, Zhi, Peng Hou, Meiju Ji, et al.. (2008). Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers. The Journal of Clinical Endocrinology & Metabolism. 93(8). 3106–3116. 307 indexed citations

9.

Vasko, Vasily, Allan V. Espinosa, Huiling He, et al.. (2007). Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proceedings of the National Academy of Sciences. 104(8). 2803–2808. 270 indexed citations

10.

Hou, Peng, Dingxie Liu, Shan Yuan, et al.. (2007). Genetic Alterations and Their Relationship in the Phosphatidylinositol 3-Kinase/Akt Pathway in Thyroid Cancer. Clinical Cancer Research. 13(4). 1161–1170. 312 indexed citations

11.

Hu, Shuiying, Dingxie Liu, Ralph P. Tufano, et al.. (2006). Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. International Journal of Cancer. 119(10). 2322–2329. 157 indexed citations

12.

Cristofaro, Julie Di, M. Marcy, Vasily Vasko, et al.. (2006). Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant. Human Pathology. 37(7). 824–830. 75 indexed citations

13.

Cristofaro, Julie Di, Vasily Vasko, В. Н. Савченко, et al.. (2005). ret/PTC1 and ret/PTC3 in thyroid tumors from Chernobyl liquidators: comparison with sporadic tumors from Ukrainian and French patients. Endocrine Related Cancer. 12(1). 173–183. 31 indexed citations

14.

Saji, Motoyasu, et al.. (2005). Akt1 contains a functional leucine-rich nuclear export sequence. Biochemical and Biophysical Research Communications. 332(1). 167–173. 73 indexed citations

15.

Stathatos, Nikolaos, Isabelle Bourdeau, Allan V. Espinosa, et al.. (2005). KiSS-1/G Protein-Coupled Receptor 54 Metastasis Suppressor Pathway Increases Myocyte-Enriched Calcineurin Interacting Protein 1 Expression and Chronically Inhibits Calcineurin Activity. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5432–5440. 68 indexed citations

16.

Kim, Caroline S., Vasily Vasko, Yasuhito Kato, et al.. (2005). AKT Activation Promotes Metastasis in a Mouse Model of Follicular Thyroid Carcinoma. Endocrinology. 146(10). 4456–4463. 90 indexed citations

17.

Vasko, Vasily, Shuiying Hu, Guojun Wu, et al.. (2005). High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5265–5269. 104 indexed citations

18.

Vasko, Vasily, et al.. (2004). Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. Journal of Medical Genetics. 41(3). 161–170. 175 indexed citations

19.

Miyagi, Eri, Milena Braga‐Basaria, Vasily Vasko, et al.. (2004). Chronic expression of RET/PTC 3 enhances basal and insulin‐stimulated PI3 kinase/AKT signaling and increases IRS‐2 expression in FRTL‐5 thyroid cells. Molecular Carcinogenesis. 41(2). 98–107. 41 indexed citations

20.

Xing, Mingzhao, Vasily Vasko, Giovanni Tallini, et al.. (2004). BRAF T1796A Transversion Mutation in Various Thyroid Neoplasms. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1365–1368. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact